The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis

Overview of attention for article published in Genetics in Medicine, May 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet
policy: 2 policy sources

twitter: 58 X users
facebook: 2 Facebook pages

Citations

dimensions_citation: 156 Dimensions

Readers on

mendeley: 153 Mendeley

Summary News Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

pembrolizumab

Cited by Canadian Agency for Drugs and Technologies in Health on 24 Apr 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

pembrolizumab and lenvatinib

Cited by Canadian Agency for Drugs and Technologies in Health on 06 Dec 2022

Konsultationsfassung: S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom: Langfassung der Leitlinie "Konsultationsfassung: S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom"

Cited by The Association of the Scientific Medical Societies in Germany on 16 May 2022

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.